| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dee3727dba91e4e7aa3b26ce9efbcc21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2853 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 |
| filingDate |
2011-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2012-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2508175-A1 |
| titleOfInvention |
Pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof |
| abstract |
The present invention relates to a new pharmaceutical composition of fesoterodine or a salt or a solvate thereof, in particular to a dry formulation. The present invention relates to a new process for the preparation of dry formulation of fesoterodine or a salt or a solvate thereof. The pharmaceutical composition is particularly useful as a medicament, especially for the treatment of urinary incontinence. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019011393-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019206391-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2867199-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015022703-A1 |
| priorityDate |
2011-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |